These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2663036)
41. [Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification]. Fournier A; Aparicio M Nephrologie; 1998; 19(3):129-30. PubMed ID: 9633056 [No Abstract] [Full Text] [Related]
42. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus. Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311 [TBL] [Abstract][Full Text] [Related]
43. Losses of 1,25- and 24,25-dihydroxycholecalciferol in the peritoneal fluid of patients treated with continuous ambulatory peritoneal dialysis. Shany S; Rapoport J; Goligorsky M; Yankowitz N; Zuili I; Chaimovitz C Nephron; 1984; 36(2):111-3. PubMed ID: 6607420 [TBL] [Abstract][Full Text] [Related]
44. [Vitamin D metabolism and chronic kidney insufficiency]. Schaefer K; von Herrath D; Kraft D Dtsch Med Wochenschr; 1973 Jul; 98(27):1338-44. PubMed ID: 4351844 [No Abstract] [Full Text] [Related]
45. Soft bones and hard arteries-can we reverse the trend in CKD? Tomlinson J; Cunningham J J Ren Care; 2009 Mar; 35 Suppl 1():28-33. PubMed ID: 19222728 [TBL] [Abstract][Full Text] [Related]
47. Metabolic abnormalities in uremia. Wilson DM Med Clin North Am; 1971 Nov; 55(6):1381-96. PubMed ID: 4942869 [No Abstract] [Full Text] [Related]
48. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure. Chan JC; Kodroff MB; Landwehr DM Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662 [TBL] [Abstract][Full Text] [Related]
49. Prevention of renal osteodystrophy. Baker LR Miner Electrolyte Metab; 1991; 17(4):240-9. PubMed ID: 1813786 [TBL] [Abstract][Full Text] [Related]
50. Hypohyperparathyroidism: a model for renal osteodystrophy? Junor BJ; Edward N Postgrad Med J; 1981 Jun; 57(668):371-7. PubMed ID: 7301683 [TBL] [Abstract][Full Text] [Related]
51. Strategies to minimize bone disease in renal failure. Martin KJ; González EA Am J Kidney Dis; 2001 Dec; 38(6):1430-6. PubMed ID: 11728986 [TBL] [Abstract][Full Text] [Related]
52. Renal bone disease in pediatric patients receiving treatment with maintenance peritoneal dialysis. Salusky IB; Goodman WG Child Nephrol Urol; 1991; 11(3):165-8. PubMed ID: 1777895 [TBL] [Abstract][Full Text] [Related]
53. [Role of vitamin D in the pathogenesis of renal osteodystrophy]. Nakanishi S; Fukagawa M Clin Calcium; 2004 Sep; 14(9):15-20. PubMed ID: 15577104 [TBL] [Abstract][Full Text] [Related]
54. [Physiopathology of renal osteodystrophy. I. Patients with kidney failure without dialysis]. Fournier A; Bordier P; Weil B; Safar M; Idatte JM Presse Med (1893); 1971 Oct; 79(45):2017-21. PubMed ID: 5119047 [No Abstract] [Full Text] [Related]
55. Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy. Hernandez JD; Wesseling K; Salusky IB Semin Dial; 2005; 18(4):290-5. PubMed ID: 16076350 [TBL] [Abstract][Full Text] [Related]
57. Some hormones, minerals and vitamin D in continuous ambulatory peritoneal dialysis. Janicka L; Ksiazek A; Twardowski Z; Kokot F Int Urol Nephrol; 1987; 19(4):453-9. PubMed ID: 3323104 [TBL] [Abstract][Full Text] [Related]
58. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis. Aloni Y; Shany S; Chaimovitz C Miner Electrolyte Metab; 1983; 9(2):82-6. PubMed ID: 6601753 [TBL] [Abstract][Full Text] [Related]
59. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]